Table 1.
Authors/Year | Dose prescription (RBE) | Difference in OAR doses (PSPT-IMPT) |
Result presented/test | ||||||
---|---|---|---|---|---|---|---|---|---|
Lung |
Heart | Oesophagus | Cord | ||||||
Combined | Ipsilateral | Contra-lateral | |||||||
Georg et al. (2008) [18] | 45 Gy, 3#, 65% isodose | N/A | Dmean: 0.2 Gy V2Gy: 3.2% V4Gy: 3.3% V6Gy: 3% V12Gy: 1.2% |
N/A | D1%: 0.2 Gy V2Gy: 0.3 cc V4Gy: −0.1 cc |
D1%: −0.2 Gy |
N/A | DIBH | Mean Statistical significance not tested |
N/A | Dmean: 0.4% V2Gy: 3.5% V4Gy: 3.6% V6Gy: 2.9% V12Gy: −1.7% |
N/A | D1%: −0.2 Gy V2Gy: 0.2 cc V4Gy: −0.1 cc |
D1%: −0.2 Gy | N/A | SB + AC | |||
Zhang et al. (2010) [21] | 74 Gy, NA | V5Gy: 5.3% V10Gy:5.3% V20Gy: 4.0% V30Gy: 3.3% Dmean: 2.7 Gy |
V5Gy: 6.2% V10Gy:7.3% V20Gy: 6.9% V30Gy: 5.4% Dmean: 4.3 Gy |
V5Gy: 4.3% V10Gy:3.0% V20Gy: 1.0% V30Gy: 1.0% Dmean: 1.0 Gy |
V40Gy: 0.8% | V40Gy: 2.6% V55Gy: 2.3% |
Dmax: −1.7 Gy D1%: 1.7 Gy |
Median Statistical significance not tested |
|
Register et al. (2011) [19] | 50 Gy, 4#, 100% isodose | V5Gy: 1.4%*** V10Gy:2.1%*** V20Gy: 1.2%*** Dmean: 0.7 Gy*** |
N/A | N/A | Dmax: 1.9Gyns | Dmax: 10.2 Gy* | Dmax: 4.8 Gy** | Mean Paired t-test |
|
Berman et al. (2013) [16] | 50.4 Gy, 28#, 95% isodose | V5Gy: 8.7%*** V10Gy:9.7%*** V20Gy: 8.2%*** V30Gy: 5.9%*** Dmean: 3.4 Gy*** |
V5Gy: 8.4%** V10Gy:11.1%*** V20Gy: 11.7%*** V30Gy: 10.2%*** Dmean: 4.8 Gy*** |
V5Gy: 8.6%*** V10Gy:8.7%*** V20Gy: 6.1%** V30Gy: 3.3%*** Dmean: 2.5 Gy*** |
V40Gy: 5.6%*** Dmean: 3.7 Gy*** |
V40Gy: 5.0%n/a Dmean: 2.2Gyn/a |
Dmax: 20.8 Gy*** D1%: 16.0Gyn/a |
Mean Paired t-test |
|
Chang et al. (2014) [17] | Dmedian = 66 Gy (45–78) | V5Gy: 1.2%ns V20Gy: 4.4%* Dmean: 2.4 Gy* |
N/A | N/A | V40Gy: 2.1%ns | V60Gy: 11.1%* | N/A | Mean Paired t-test Values were digitised from graph. |
|
Lin et al. (2015) [24] | 66.6 Gy in 18#, 99% isodose | V5Gy: 4.3%** V20Gy: 4.5%*** Dmean: 2.3 Gy*** |
N/A | N/A | V30Gy: 2.3%** V45Gy: 2.0%ns Dmax: 4.5 Gy* |
Dmax: 3.7 Gy* | Dmax: 5.3 Gy* |
Mean Paired t-test |
|
Zeng et al. (2016) [20] | 30.6 Gy in 17#, 97% isodose | V5Gy: 5.0%* V10Gy:5.0%* V20Gy: 6.0%* V30Gy: 4.0%* Dmean: 2 Gy* |
N/A | N/A | V5Gy: 2.0%ns V10Gy: 2.0%* V20Gy: 4.0%* V30Gy: 8.0%* Dmax: 2.0 Gy* Dmean: 1.3 Gy* |
N/A | Dmax: 10 Gy* | Median Wilcoxon signed rank test |
Abbreviations: IMPT = intensity modulated proton therapy; PSPT = passive-scattered proton therapy; RBE = Radiobiological Effectiveness, OAR = organ-at-risk; DIBH = deep inspiration breath-hold; SB + AC = shallow breathing and abdominal compression; N/A = Not available; VxGy = volume of OAR receiving × Gy; Dmean = mean dose; Dmax = max dose; Dmedian = median dose; Dx% = Dose to x% volume of OAR.
p ≤ 0.05.
p ≤ 0.01.
p ≤ 0.001.
p > 0.05.
p-value not reported.